ETON Eton Pharmaceuticals Inc.

7.08
+0.07  (+1%)
Previous Close 7
Open 6.91
Price To Book 6.49
Market Cap 124,717,591
Shares 17,627,928
Volume 17,089
Short Ratio
Av. Daily Volume 69,444

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

CRL issued June 12, 2019
EM-100
Allergic conjunctivitis
NDA filing planned for 2020.
ET-102
Multiple sclerosis
NDA to be filed in 2020.
DS-100
Intractable pain
Rolling NDA filing announced March 14, 2019. However, third-party has been granted five years of market exclusivity.
DS-200
Nutritional deficiencies
aNDA (not NDA) to be filed later in 2019.
DS-300
Nutritional deficiencies
PDUFA date October 21, 2019.
ET-202
Injectable hospital product
Bioequivalence study data due 3Q 2019.
EM-103
Hypothyroidism
NDA filing due 3Q 2019.
ET-203
Injectable hospital product
Trial to be initiated 2Q 2019.
EM-104
Neurological indication
NDA filed May 2019.
EM-105
Lennox-Gastaut syndrome, epilepsy

Latest News

  1. Eton's Ophthalmic Solution Candidate Gets CRL, Shares Fall
  2. Eton Pharmaceuticals Shares Slammed After FDA Complete Response Letter
  3. Eton Pharma's conjunctivitis treatment fails to win FDA approval
  4. Eton Pharmaceuticals Provides Update on EM-100 Program
  5. Could The Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Ownership Structure Tell Us Something Useful?
  6. The city's newest public company wants to build a new industry in Nashville
  7. Publicly traded San Diego firm moving HQ to Nashville
  8. The Daily Biotech Pulse: Hematology And Rheumatology Conference Presentations Take The Spotlight, Eton In-Licenses Epilepsy Drug NDA
  9. Eton Pharmaceuticals Announces Licensing of Lamotrigine New Drug Application and Provides Pipeline Update
  10. How Many Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Shares Did Insiders Buy, In The Last Year?
  11. Eton Pharmaceuticals to Present at 20th Annual B. Riley FBR Investor Conference
  12. Eton Pharmaceuticals Reports First Quarter 2019 Financial Results and Highlights Business Progress
  13. Bausch's (BHC) Q1 Earnings Beat Estimates, Revenues Miss
  14. Eton Pharmaceuticals to Report First Quarter 2019 Financial Results on Tuesday, May 7, 2019
  15. Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results and Highlights Business Progress
  16. Eton Pharmaceuticals Submits New Drug Application for DS-200
  17. Bausch (BHC) Q4 Earnings Beat Estimates, Revenues Down Y/Y
  18. Eton Pharmaceuticals to Present at the 8th Annual SVB Leerink Healthcare Conference
  19. The Daily Biotech Pulse: Teva Settles With FTC, Setback For Merck In Liver Cancer Trial, Sienna Biopharma Offering
  20. Bausch Health Acquires Eton Pharmaceuticals' EM-100 Investigational Eye Drop For The Treatment Of Itchy Eyes Associated With Allergies